The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol-Reference-Cited by-同舟云学术

The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol

Published:2023-11-15 Issue:1 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

López‑Méndez José¹,Ventura‑Gallegos José²,Camacho‑Arroyo Ignacio³,Lizano Marcela²,Cabrera‑Quintero Alberto²,Romero‑Córdoba Sandra²,Martínez‑Vázquez Mariano⁴,Jacobo‑Herrera Nadia⁵,León‑Del‑Río Alfonso²,Paredes‑Villa Adrian²,Zentella‑Dehesa Alejandro²

Affiliation:

1. Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, 04510 Mexico City, Mexico

2. Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510 Mexico City, Mexico

3. Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología‑Facultad de Química, Universidad Nacional Autónoma de México, 11000 Mexico City, Mexico

4. Departamento de Productos Naturales, Instituto de Química, Universidad Nacional Autónoma de México, 04510 Mexico City, Mexico

5. Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 14000 Mexico City, Mexico

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference43 articles.

1. Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer;Lv;Ther Adv Med Oncol,2021

2. Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2-breast cancer subtypes;Parise;Cancer Causes Control,2019

3. Triple positive breast cancer: A distinct subtype?;Vici;Cancer Treat Rev,2015

4. Luminal-B breast cancer and novel therapeutic targets;Tran;Breast Cancer Res,2011

5. Tracking progesterone receptor-mediated actions in breast cancer;Knutson;Pharmacol Ther,2014